HC Wainwright Has Strong Forecast for DMAC FY2025 Earnings
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) – Stock analysts at HC Wainwright raised their FY2025 earnings estimates for shares of DiaMedica Therapeutics in a note issued to investors on Thursday, May 15th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings per share of ($0.72) for the year, up from […]
